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Abstract: 
 
Iron deficiency (ID) is one of the most common nutritional problems worldwide that is 
considered as the main cause of anemia. Adolescents are vulnerable to ID because of 
increased iron requirements related to rapid growth. Iron needs are highest in males 
during peak pubertal development because of a greater increase in blood volume, 
muscle mass and myoglobin. However, women in general and during their reproductive 
years are at risk of ID due to blood loss from menstruation. This study aimed to 
determine the prevalence of iron deficiency and iron deficiency anemia among 
university students in Palestine.  
This is a cross-sectional study conducted among university students in Palestine. Five 
hundred blood samples were collected from students in different Palestinian universities 
that covered South, North, West and East of the West-Bank, Palestine. The student’s 
age ranged between 18 to 26 years. The study participants were recruited voluntarily 
and were asked to fill the study questionnaire. The data collected from the questionnaire 
covered the socio-demographic aspects of university students such as age, gender, 
weight, height, BMI, food habits, disease symptoms, dietary and medical history. CBC 
was measured for all participants (N=500) and iron profile were measured for 
participants who have MCV< 80 fl (N=43). Data were analyzed statistically by Chi- 
square test for categorical variables. ANOVA and independent sample t- test for 
continuous variables and Pearson’s correlation for testing correlations. 
The prevalence of anemia among the study subjects was 4.7% (23 out of 500) judged by 
WHO definition of anemia, Hb level (Hb < 12 g/dl for females and <13.5 g/dl for 
males). Based on the analysis of serum ferritin (SF) for participants who have MCV < 
80 fl, 20.9% (9 out of 43 subjects) of the study subjects showed depleted iron stores 
(ID) and 14.0 % ( 6 out of 43 ) of the study subjects  showed IDA (both Hb and SF 
VII 
are low). When university students were grouped into three tertile groups and analyzed 
for to student’s habits like smoking water pipe, smoking cigarettes, drinking coffee and 
tea (P= 0.031),  no statistically significant difference was observed among Hb tertile 
groups when compared for Age, BMI, SI, SF, TIBC, students suffering from symptoms 
of anemia and student’s knowledge of anemia. There was a significant correlation 
between the family income of the students and smoking habit (cigarettes smoking, water 
pipe).  
In conclusion, our data revealed that the prevalence of ID is 1.8% (9 out of 500) and 
prevalence of IDA is 1.2% (6 out of 500) among university students in Palestine. Our 
study showed that the level of university student’s general knowledge and background 
about anemia is very good, because 84.4% of students have enough idea about anemia 
as disease. On other hand, 83.9% and 86.6% of students realize that poor nutrition and 
ID respectively, were the main cause of anemia. The result of their knowledge regarding 
poor nutrition and ID as main cause of anemia helps them protect themselves from the 
distribution of ID and IDA. Our study revealed that 92.4% of the students were medium 
and high family income, that’s mean that the medium and high social-economic level of 
individuals play a role in reduced figures of ID and IDA. 
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Chapter One 
Introduction 
 
1.1 Introduction 
 
Anemia is the most common nutritional deficiency disorder in the world. WHO has 
estimated that about one third of the global population (over 2 billion) is anemic 
(Kalaivani, 2009). Globally, the most significant contributor to the onset of anemia is 
iron deficiency (ID) so that ID and anemia are often used synonymously, and the 
prevalence of anemia has often been used as a proxy for iron deficiency anemia (IDA). 
It is generally assumed that 50% of the cases of anemia are due to ID. It occurs at all 
stages of life cycle, but is more prevalent in pregnant women and young children. In 
2002, IDA was considered to be among the most important contributing factors to the 
global burden of disease.  The etiology of IDA is multifactorial, it is typically caused by 
inadequate intake of iron, chronic loss or a combination of both (Clark, 2009, WHO and 
CDC, 2008). 
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Adolescents are vulnerable to ID because of increased iron requirements related to rapid 
growth. Iron needs are highest in males during peak pubertal development because of a 
greater increase in blood volume, muscle mass and myoglobin. After menarche, iron 
needs continue to remain high in females because of menstrual blood loss, which 
averages about 20 mg of iron per month, but may be as high as 58 mg in some 
individuals. Oral contraceptives decrease menstrual losses, while some intrauterine 
devices may increase losses (Beard, 2001). 
 
ID is the predominant nutritional deficiency causing anemia and is present even when 
other causes of anemia are recognized. The relative proportion of anemia due to ID 
increases as the prevalence of anemia increases (UNICEF/UNU/WHO, 2001). 
 
The nutrition unit of the WHO’s regional office for the Eastern Mediterranean Region  
showed that  the prevalence of anemia in Morocco was 30.1% among women of child 
bearing age and 9.9% among adult men. While the prevalence of anemia among women 
of child bearing age in Pakistan was 22.5%. They also found that the prevalence of 
anemia among women of child bearing age in Syrian Arab Republic and Palestine were 
40.8% and 36.2% respectively (Bagchi, 2004). 
 
 
1.2 Research questions 
 
The investigation was initiated to answer the following questions 
- What is the prevalence of ID & IDA among university students in Palestine? 
- Is there an association between the socio-economic status of individuals and ID 
& IDA? 
- Role of smoking habits in ID and IDA pathogenesis among study population? 
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1.3  Objectives 
The objectives of this study are: 
- To estimate the prevalence of ID & IDA among university students in Palestine. 
- To design a questionnaire summarizing social- economic factors, and medical 
history of individuals and correlates between many factors in the process of ID 
and IDA pathogenesis. 
- To investigate the association between socio-economic factors and ID & IDA. 
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Chapter Two 
Literature Review 
 
2.1  Background 
IDA is considered to be one of the top ten contributors to the global burden of disease 
(WHO and CDC, 2008). It is known  to  affect  the  health  and  cognitive  ability  of  
children  and adolescents (Abalkhail and Shawky, 2002).  The WHO estimates that 
about one third of the global population (over 2 billion) is anemic (Kalaivani, 2009). 
 
Iron deficiency is defined as a condition in which there are no mobilizable iron stores 
and in which signs of a compromised supply of iron to tissues, including the erythron, 
are noted. The more severe stages of iron deficiency are associated with anemia 
(UNICEF/UNU/WHO, 2001, CDC, 1998) 
  
Anemia pathogenesis is a result of either increased destruction of red blood cell or 
decreased production of red cell (marrow failure). The peripheral blood loss may be 
caused by bleeding or hemolysis that include extrinsic or intrinsic red cell defect. The 
decreased marrow output (Erythropoiesis) includes stem cell defect, erythroid hypo-
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proliferation, marrow infiltration (metastasis, lymphoma, myeloma, and fibrosis) and 
nutritional deficiency like iron, B12 and folate. The general symptoms of anemia are 
non specific and indicate inadequacy of oxygen transport to tissue or decreased 
intravascular volume (Rodgers and Young, 2005). 
 
In developing countries, low iron bioavailability of the diet is the primary cause of IDA 
(Bermejo and Garcia-Lopez,2009); however, decreased iron absorption and blood loss 
account for the more likely etiologies of ID in developed countries,  there are several 
factors caused decreased iron absorption such as malabsorption syndromes especially 
celiac disease or  atrophic gastritis. Chronic blood loss from genitourinary, 
gynecological, or gastrointestinal tracts accounts the majority of causes for IDA. IDA is 
especially prone to occur in those taking aspirin or non steroidal anti-inflammatory 
drugs chronically (Johnson-Wimbley and Graham, 2011, Bermejo and Garcia-Lopez, 
2009). 
 
For development of ID there are some risk factors including; age (infants and 
postmenopausal are with higher risk than adolescents), gender (increased in women), 
presence of reproductive and renal disorders like hematuria, presence of gastrointestinal 
tract bleeding, patient with neoplasm, social, and physiological and drug history also 
play a role in the development of IDA (UNICEF/UNU/WHO, 2001, Rebecca, 2001). 
 
The total iron content of the health adult human body is about 3.5 to 4 g in women and 
4 to 5 g in men. Nearly 70% of this is stored in Hb, 20% in the body’s iron depot, 10% 
in iron containing enzymes and myoglobin, and only 0.1 to 0.2% is bound to transferrin 
as transport iron (Wick et al., 2011) 
 
The human diet contains two forms of iron: heme iron and nonheme iron. Heme iron is 
derived from meat and is well absorbed. However, non heme dietary iron, which is 
found in cereals, beans, and some vegetables, is less well absorbed. Nonheme iron is 
present as either ferric (Fe+2) or ferrous (Fe+3) iron.  (Johnson-Wimbley and Graham, 
2011, Bermejo and Garcia-Lopez, 2009). 
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Several dietary factors can influence iron absorption. Inhibiting factors are plant 
components in vegetables, tea and coffee (e.g., polyphenols, phytates), and calcium; 
absorption enhancing factors are ascorbic acid and meat, fish and poultry. The 
following recommendations are made for people at risk of ID. Increase heme-iron 
intake (this form of dietary iron present in meat fish and poultry is hardly influenced by 
other dietary factors with respect to its absorption); increase meal-time ascorbic acid 
intake; fortify foods with iron. Recommendations with respect to tea consumption 
include: consume tea between meals instead of during the meal; simultaneously 
consume ascorbic acid and/or meat, fish and poultry (Zijp, Korver et al. 2000). 
 
2.2 Etiology of IDA 
 
There are many potential causes of ID and IDA and some of them are very relevant. 
These causes are clearly different in developed and in developing countries. In 
developed countries, the likeliest cause of anemia in each patient depends on age and 
sex. In women of childbearing age, excessive menstrual loss is the most frequent 
etiology, while in males; digestive diseases are the main causes (Bermejo and Garcia-
Lopez, 2009). 
  
Digestive disorders, urological diseases, gynecological diseases and other specific 
situations, such as intravascular hemolysis are main causes of ID or IDA. Focusing on 
digestive diseases, the etiology of ID and IDA of gastrointestinal origin can be divided 
into two groups: situations with increased loss of iron (the most common in developed 
countries), and those with decreased iron absorption (Bermejo and Garcia-Lopez, 2009, 
Rodgers and Young, 2005). 
 
Gastrointestinal malignancies are uncommon in premenopausal women with ID or IDA, 
but in men and postmenopausal women with ID or IDA gastrointestinal malignancies 
are more common than in individuals with normal hemoglobin and iron levels (Bermejo 
and Garcia-Lopez, 2009, Rodgers and Young, 2005). 
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2.3 Clinical symptoms of IDA 
 
Several common symptoms of IDA are well defined but individuals may experience 
these symptoms differently. The symptoms include: fatigue, pallor, (stress-) dyspnea, 
headache, concentration disorders, chest pain, dizziness, cold hands and feet, sore 
tongue, brittle nails and enlarged spleen (Rodgers and Young, 2005, Krayenbuehl, 
Naumann et al., 2007).  Rarely, a person with IDA may experience pica, a craving to eat 
nonfood items such as paint chips, chalk, or dirt. Pica may be caused by a lack of iron in 
the diet. IDA may also impair temperature regulation and cause pregnant women to feel 
colder than normal (Pavord, Myers et al., 2012). 
 
2.4 Laboratory tests 
2.4.1 Full blood count and red cell indices 
 
ID is usually diagnosed by laboratory tests. Low serum hemoglobin (Hb) in the setting 
of a reduced MCV is usually the initial ﬁnding on a routine CBC. RDW has been 
proposed as a sensitive indicator for IDA. A signiﬁcant increase in mean RDW can be 
used to diagnose IDA. An inverse relationship is also observed between the serum Hb 
and the RDW in IDA (Zhu, Kaneshiro et al., 2010). 
 
2.4.2 Serum ferritin 
 
Ferritin is a major iron storage protein and is plays an essential role in a wide range of 
physiologic and pathologic processes and plays also a role in iron homeostasis. In 
clinical medicine, ferritin is predominantly utilized as a serum marker of total body iron 
stores (Knovich, Storey et al., 2009) 
 
Serum ferritin (SF) is considered as one of the best laboratory tests for evaluation of 
iron deficiency as measurement of SF directly related to iron storage. However, 
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inflammation is major problem seems to be associated with this test; a problem must be 
taken in consideration when thinking of use of this test. Serum apoferritin is an acute-
phase reactant protein and is therefore elevated in response to any infectious or 
inflammatory process. Consequently, SF in the normal range reflects only iron 
sufficiency in the absence of these conditions (UNICEF/UNU/WHO,2001; Abu- Hasira, 
2007). 
 
2.4.3 Serum iron, Serum transferrin and total iron binding capacity 
 
Serum iron (SI) concentration is a measure of the total amount of iron in the serum. ID 
results in a reduction in SI levels, an elevation in transferrin (total iron-binding capacity 
[TIBC]) levels, and hence a net reduction in transferrin saturation (TS). Transferrin 
saturation is calculated by dividing SI concentration by TIBC and multiplying by 100 to 
express the result as a percentage: 
Transferrin saturation (%) = [ SI concentration (µg/dL) / TIBC (µg/dL)] × 100 
(UNICEF/UNU/WHO, 2001, CDC, 1998). 
 
An increase in serum transferrin receptors is a sensitive response during the early 
development of ID. Serum transferrin receptor levels increase progressively as the 
supply of iron to the tissues becomes progressively more deficient. Major advantages of 
measuring serum transferrin receptors involve the facts that the assay is not significantly 
affected by infection or inflammatory processes, and it does not vary with age, gender, 
or pregnancy. Serum tranferrin is measured by calculating TIBC (ng/dl) / 1.25 
(UNICEF/UNU/WHO,2001, Knovich et al., 2009). 
 
TIBC indicates the maximum amount of iron needed to saturate plasma or serum 
transferrin, which is the primary iron-transport protein. Measurements of TIBC, SI, and 
the percentage of iron saturation of serum transferin are useful for the clinical diagnosis 
of IDA. As an alternative to direct measurement methods (Zhu et al.,2010) 
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2.5 Treatment of IDA 
 
Iron supplements are essential for the rapid treatment of severe IDA in all sex and age 
groups. In many populations, the amount of iron absorbed from the diet is not sufficient 
to meet many individuals’ requirements. If the amount of absorbable iron in the diet 
cannot be immediately improved iron supplementation will be a necessary component 
of programs to control IDA (INACG), (WHO) and (UNICEF) (1998). 
 
 
Oral iron:  
Body stores of iron can be restored in most patients by oral iron therapy. Iron is equally 
well absorbed from several simple ferrous iron salts, and as ferrous sulphate is the 
cheapest, this is also the drug of first choice. The side effects of oral iron, such as 
nausea, epigastric pain, diarrhea and constipation, are related to the amount of available 
iron they contain (Hoffbrand et al., 2011). 
 
Studies in women and children have shown lower doses of oral iron may be effective 
and associated with fewer GI side effects (Zhou SJ et al., 2009). In adults, lower doses 
can be administered through either intermediate-dose tablets (containing around 30–
60 mg of elemental iron) or intermittent dosing (e.g., second daily to weekly); the latter 
approach has been recommended by the WHO for some developing countries. Either 
approach may be useful in patients with mild IDA who experience GI upset with 
standard doses of iron, but rapid Hb rise is not essential (Pasricha, Flecknoe-Brown et 
al. 2010). 
 
Intravenous (i.v.) iron: 
The use of i.v. iron has increased dramatically over the last five years. Several i.v. iron 
preparations are available worldwide include iron dextran, iron dextrin, iron 
hydoxysaccharate and iron sodium gluconate (Macdougall, 1999) 
 
There are two types of reaction to i.v. iron. The first is a type I IgE- mediated 
anaphylactic reaction, which is seen exclusively to iron dextran and is due to preformed 
dextran antibodies whereas the second reaction is anaphylactoid in nature, causing 
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different symptoms such as wheezing, myalgia, breathlessness, nausea, abdominal or 
back pain and hypotension (Macdougall, 1999) 
 
Transfusion of packed red blood cells: 
Transfusion of red cells remains an overused treatment for IDA.  It is also expensive 
and potentially hazardous. In physiologically compensated patients, transfusion carries 
unnecessary risks and fails to replenish deficient iron stores (Pasricha, Flecknoe-Brown 
et al. 2010). 
 
Transfusion is associated with adverse outcomes, including fluid overload (around 1% 
of patients), and a range of immunological and infectious hazards. Hence, it should be 
reserved for immediate, targeted management in patients with severe anemia 
compromising end-organ function (eg, angina pectoris or cardiac failure) or where IDA 
is complicated by serious, acute ongoing bleeding (Pasricha  et al. 2010). 
 
 
2.6 Prevalence of IDA 
 
IDA is considered to be one of the top ten contributors to the global burden of disease 
(WHO and CDC, 2008). It is known  to  affect  the  health  and  cognitive  ability  of  
children  and adolescents (Abalkhail and Shawky, 2002).  The WHO estimates that 
about one third of the global population (over 2 billion) is anemic (Kalaivani, 2009).  
 
A worldwide survey conducted by WHO and CDC and covering the years 1992-2005 
found that the prevalence of anemia among non pregnant women aged between 15–50 
years is 30.2% where the prevalence of anemia among men (15-50 years) is 12.7% 
worldwide. The prevalence of anemia ranges widely among developing and developed 
countries, where the prevalence of anemia among non pregnant women was 21.5% in 
the Western pacific, 19.0% in Europe, 32.4% in Eastern Mediterranean region which 
includes most Arabic countries and 17.8% in South East Asia (WHO and CDC, 2008). 
 
In Kavar Urban Area in Southern Iran, Haghpanah et al. (2011) found that 5.8% of 
adolescent  girls had anemia (Hb<12), 8.5% of them had iron deficiency (serum 
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ferritin< 12) and 1.7% of adolescent girls had iron deficiency anemia (Hb<12 and serum 
ferritin< 12). Most of the anemic girls (85.7%) were in the mild range of anemia, only 
three of them had moderate anemia and severe anemia was not seen. There was not 
significant correlation between hemoglobin concentration and serum ferritin, but a 
significant negative correlation between hemoglobin concentration and TIBC 
(Haghpanah et al., 2001). 
 
The Palestinian Ministry of Health (MoH) has protocols for IDA management and 
prevention that involves free iron supplements. Anemia has been shown to increase with 
age. In Palestine women aged 40-49 are four times more likely to suffer from anemia 
than adolescent women. However, the percentage of women aged 15-49 years taking 
iron was only 7.1 % (PNA, 2005). 
 
Prevalence of IDA among women (non pregnant) in Palestine is 34.8% which is higher 
than in neighboring countries, such as  Lebanon (20%), Egypt (26.3%) and Jordan 
(28.2%) (PNA,2005). 
 
 
2.7 Problem statement 
 
Anemia and in particular IDA is a common public health problem worldwide. 
University students as a target group, some of them are living within refugee campus, 
and suffering from nutritional insufficiency. Prevalence of ID and IDA among 
university students in Palestine could be an important public health issue. Once there is 
no enough published data regarding this issue. 
 
 
2.8 Justification 
 
IDA is considered to be one of the top ten contributors to the global burden of disease. 
ID constitutes about 50% of all causes of anemia. The determination of ID and IDA 
among Palestinian university students should provide primary health care providers and 
policy makers in health field with necessary data needed for health care assessment.  
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Identification of risk factors associated with ID and IDA among Palestinian university 
students and its association with lab tests values should help in developing the 
intervention to reduce ID and IDA. Additionally, the results of this study can be used as 
a baseline in monitoring the implementation of a national anemia policy. 
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Chapter Three 
Materials and Methods 
 
3.1  Materials 
The materials used in this study are shown Table 3.1. 
 
Table 3.1: Materials used in this study. 
# Item Manufacture company 
1 Needles  
2 Evacuated Tube Blood 
Collection System 
 
3 3.5 ml Plain Tubes  
4 3.5 ml EDTA Tubes  
5 Tourniquet  
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# Item Manufacture company 
6 Sterile Gauze Swabs  
7 Cobas Ferritin Reagent 
Kits, Catalog # 
Roche/ Hitachi cobas c 
systems, Germany 
8 Cobas Transferrin Reagents 
kits, Catalog # 
Roche/ Hitachi cobas c 
systems, Germany 
9 Cobas Iron Reagents Kits, 
Catalog# 
Roche/ Hitachi cobas c 
systems, Germany 
10 Cobas Ferritin Controls  
Catalog # 
Roche/ Hitachi cobas c 
Systems, Germany 
11 Cobas Transferrin Controls 
Catalog # 
Roche/ Hitachi cobas c 
Systems, Germany 
12 Cobas Iron Controls 
Catalog # 
Roche/ Hitachi cobas c 
Systems, Germany 
 
3.2  Methods 
 
3.2.1 Study Design 
A cross sectional study was conducted to detect prevalence of ID and IDA among 
university students in Palestine. The blood samples were collected from different 
universities that covered South, North, West and East of Palestine. The average age of 
individuals ranged between 18 to 26 years. 
 
3.2.2 Study Questionnaire 
After a detailed review of published and recommended by WHO questionnaires related 
to ID &IDA. We developed our own questionnaire to match the needs and the 
parameters of the Palestinian society life style, food habits, social and economic 
situation. The researcher helped the individuals participating in the study to fill this 
questionnaire. 
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The aspects of the questionnaire include personal data (Age, gender, weight, height, 
BMI, food habits), medical history such as chronic disease, metabolic disorders, and 
dietary disease), socio-economic and demographic aspects. 
 
3.2.3. Study Sample 
Five hundred blood samples were collected from students in different 
universities in Palestine. The amount of 6 cubic centimeters was collected in 
Ethylenediaminetetraacetic acid (EDTA) tube and plain tube. The average age 
of individuals ranged between 18-26 years. 
 
Table 3.2 List of Palestinian universities from which the study samples were 
collected 
Palestinian Universities Number of Students 
 
       Males         Females       
 
 
Total 
Al-Quds Open University- Bethlehem & Ramallah 70                          36 106 
Palestine Polytechnic University –Hebron 77                          23 100 
Al- Quds University – Abu Dees 70                          65 135 
Arab American University- Jenin 33                          42 75 
Palestine Ahleya University – Bethlehem 56                         28 84 
Total    306                    194              500 
 
3.2.4 Collection of blood samples 
Convenient samples were asked to donate a blood sample for the purpose of this study 
and provide all information required to fill up the questionnaire.  
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From random university students, 3 ml of whole blood in plain tubes and 3ml of whole 
blood in EDTA tubes were collected. The EDTA tubes were used within 2- 12 hours for 
CBC testing. While the blood in plain tube was allowed to clot at room temperature, 
centrifuged blood and serum were collected and stored at between -18 to -25 ºC in 
Caritas Baby Hospital in Bethlehem and used later for determination of Serum iron, 
Transferrin and Ferritin. 
 
3.2.5 Analysis of blood samples 
CBC was the first test that we used to diagnose IDA. CBC was performed for all five 
hundred participants at Al- Quds University (AQU) laboratory; the CBC machine was 
calibrated using standard quality assurance. Nihon Kohden 6450 Cell Counter machine 
was used. The automated hematology analyzer was calibrated using the appropriate 
calibrators. Reliability of tests was assessed by running appropriate controls. 
 
SI, SF and Transferrin were measured by using Roche Cobas c311 machine. Based on 
MCV, all individuals with a value less than 80 fl were considered to be at risk for ID 
and were subjected to SI, SF and Transferrin blood tests. 
 
Blood samples were obtained following standard methods by the researcher in a 
qualified researcher preventing clot and hemolysis formation, and then blood samples 
were transferred under optimal temperature and conditions to Caritas Baby 
Hospital in Bethlehem where SI, transferrin and SF were performed using Roche Cobas 
c311 machine based on scientific memorandum of cooperation between the department 
of pathology in AQU and the Caritas baby hospital in Bethlehem.  
 
Iron deficiency is defined as a condition in which there are no mobilizable iron stores 
and in which signs of a compromised supply of iron to tissues, including the erythron, 
are noted. The more severe stages of ID are associated with anemia 
(UNICEF/UNU/WHO, 2001, CDC, 1998) 
 
Anemia is defined as Hb concentration lower than the established cut off defined by 
WHO, anemia is less than 12g/dl for non pregnant women and less than 13g/dl for adult 
males. According to CDC and WHO the ID is the number one in nutritional disorder in 
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world, where 80% of world’s population is iron deficient while 30% iron deficient 
anemia in some form (UNICEF/UNU/WH.O, 2001, CDC, 1998) 
 
According to the WHO/UNICEF/UNI recommendations, IDA for non pregnant women 
was defined as a situation when Hb is less than 12 g/dl; ferritin is less than 15 ng/ml. 
However, WHO/UNICEF/UNU recommendations defined ID for non pregnant women 
as a situation when Hb greater than or equal to 12 g/dl, ferritin is less than 15 ng/ml 
(WHO/UNICEF/UNU, 2001, Al-Sayes et al., 2011). 
 
 
3.2.6 Statistical analysis 
 
Data obtained from questionnaires and results of students blood tests were analyzed 
using software program statistical package for social sciences (SPSS) version 20. 
Frequencies and percentages were calculated and chi-square test was performed to 
investigate the significance in the association of the different variables and the 
prevalence of IDA among university students. A P-value <0.05 was considered as 
statistically significant. 
 
 
3.2.7 Ethical consideration 
A permission to recruit study subjects was obtained from participating universities. All 
study individuals were briefed of the purpose and objectives of the study and they were 
asked to sign a consent written to participate in the study by providing all information 
needed to fill the questionnaire and donate a blood sample. 
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Chapter Four 
Results 
 
Globally, the most significant contributor to the onset of anemia is ID so that ID and 
anemia are often used synonymously, and the prevalence of anemia has often been used 
as a proxy for IDA (Clark, 2009, WHO and CDC, 2008). This study was designed to 
examine the prevalence of ID and IDA among university students in Palestine. Data and 
blood sample were collected during the period from September 2012 to January 2013. A 
total of 500 university students who have MCV< 80 fl were included in this study, we 
helped the students to fill a special questionnaires. Pregnant students, students with 
MCV>80 fl and students with recent blood transfusion were excluded from this study. 
 
The geographic distribution (Urban and Suburban) of different university students in 
Palestine is described in table 4.1. The numbers of students from villages, cities and 
refugee camps were 49.3%, 43.5% and 7.2% respectively. 
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Table 4.1: Geographic distribution (Urban and Suburban) among different 
university students in Palestine. 
 
 Geographic Distribution 
(Urban and Suburban) 
 
  
Male Female Total 
Count  %  Count %   Count Total N % 
Residence-Palace 
Cities 
 
125 
 
25.7% 87 17.9% 212 43.5% 
Villages 
 
164 
 
33.7% 76 15.6% 240 49.3% 
Refugee 
Camps 
 
26 5.3% 9 1.8% 35 7.2% 
 Total 315  64.7%  172 35.3% 487 100% 
 
The general characteristics (age, BMI) and biochemical status (Hb, MCV, Hct, SI, SF, 
TIBC and serum transferrin) of the study samples are described in table 4.2. The mean 
age of 500  university students was 21 years (range 18-26 years) and the mean BMI was 
23.59 kg/m² (range 14.53-56.34 kg/m²). Where the mean Hb of the students (N= 500) 
was 15.49 g/dl (range 5.10-20.10 g/dl) and the mean SF measured and serum transferrin 
for students who have MCV < 80 fl (N=43) were 55.0 and 344.9 respectively. 
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Table 4.2: General characteristics of university students in Palestine. 
 
 
         General Characteristics  
 
 
  
 
N 
 
Mean ± SD 
 
Minimum 
 
Maximum 
 
Age 485 21 ± 3 18 26 
BMI (kg/m²) 471 23.6 ± 4.4 14.5 56.3 
 
Biochemical status 
    
Hb (g/dl) 500 15.5 ± 2.1 5.1 20.1 
MCV (fl) 500 87.9 ± 6.2 51.4 100 
Hct (%) 500 44.8 ± 5.5 16.2 57.8 
SF (ng/ ml) 43 55.0 ± 65.8 2.0 338 
TIBC (g/dl) 43 431.0 ± 95.1 269 706 
Serum transferrin (mg/dl) 43 344.9 ± 76.0 215 565 
Transferrin saturation (%) 43 17.6 ±12.9 2.2 62.8 
 
Table 4.3 (a) shows the Hb status among the university students (N=500). Out of 500 
university students, 23 students (4.7%) are anemic based on the recommendation of 
WHO (WHO, 2001).  Table 4.3 (b) shows the serum ferritin status among the university 
students that have MCV less than 80 fl (N=43). Out of 43 students who have MCV less 
than 80 fl, the analysis of serum ferritin levels showed that 14.0% (6 out of 43) of 
students showed IDA (IDA is used when Hb and SF are low) which based on 
recommendation of the WHO (UNICEF/UNU/WHO, 2001).  And 20.9%  of students (9 
out of 43 students)  had ID. 
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Table 4.3 (a): Hb status among the university students (n=500). 
  
Frequency (n) 
 
Percentage (%) 
 
Hemoglobin   
 Anemic * 23 4.7% 
 Adequate  477 95.3% 
*:  WHO definition of Anemia (Anemic has Hb less than 12 for female or 13.5 for male) 
  
Table 4.3 (b):  Serum Ferritin status among the university students (n=43). 
  
Frequency (n) 
 
Percentage (%) 
 
Serum Ferritin 
Normal (≥ 15 ng/ml) 28 65.1% 
ID (≤ 15ng/ml) 9 20.9% 
IDA (≤ 15 ng/ml) 6 14.0% 
 
 
Table 4.4 (a) shows the biochemical status of ID university Students (N=9). The mean 
Hb of ID students was 13.3 g/dl and mean SI of students was 35.60 µg/dl where the 
biochemical status of IDA university students (N=6) is also shown in table 4.4 (b), 
where the mean SF was 5.5 ng/dl and the mean of TIBC was 482.9 g/dl. 
 
 
 
Table 4.4 (a):  Biochemical status of ID university students (N = 9) 
 
 
N Mean ± SD 
Hb (g/dl) 9 13.3 ± 1.1 
MCV (fl) 9 76.1 ±2.0 
RDW (%) 9 14.8  ±1.8 
SI (µg/dl) 9 35.60 ±26.1 
SF (ng/ml) 9 8.20 ±2.5 
Serum Transferrin (mg/dl) 9 364.7 ±70 
TIBC (g/dl) 9 441.5±67.6 
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Table 4.4 (b):  Biochemical status of IDA students (N = 6) 
 
 
N Mean ± SD 
Hb (g/dl) 6 10.6 ± 1.6 
MCV (fl) 6 71.3 ±7.20 
RDW (%) 6 15.0 ±1.3 
SI ( µg/dl) 6 24.8 ±11.7 
SF (ng/ml) 6 5.5 ±4.0 
Serum Transferrin (mg/dl) 6 386.2 ±95.6 
TIBC (g/dl) 6 482.9 ± 119.4 
 
 
Cigarette smoking is a worldwide major cause of preventable morbidity and mortality 
(Funck-Brentano, Raphael et al. 2006). According to research in Sudan a statistical 
analysis revealed that SI was significantly higher in smokers compared to non smokers. 
SI did not change due to age difference. There was insignificant difference between the 
mean of serum iron in smokers who smoked ≤15 cigarettes per day compared to those 
who smoked ≥15 cigarettes per day. No correlation found between iron level and the 
number of cigarettes per day, also no correlation found between iron level and duration 
of smoking. Table 4.4 (a+b) reveals that none of IDA students smoke cigarette and 
water pipe. And 1 out of 9 ID students smoke cigarette, our results showed that IDA not 
related with smoking because none of them smoke cigarette and water pipe. 
 
Smoking can be considered as one of the most dangerous habits that any one individual 
can have. The WHO estimates that tobacco caused 5.4 million deaths in 2004. The 
result of our study shows that 54.8% and 63.4% of the Palestinian university student’s 
smoke at all neither water pipe nor regular cigarettes respectively; however 11.1% and 
20.2% of them are frequent smokers of water pipe and cigarettes respectively. 
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   Figure 4.1 Smoking habits among university students 
 
Table 4.5 (a) shows the student’s characteristics by Hb tertile groups. As shown in 
Table 4.5 (a) , a statistically significant difference was observed among the Hb tertile 
groups when compared with students habits include  smoking water pipe, smoking 
cigarettes tobacco, drinking coffee and tea (P= 0.031). Our study showed that 3 out of 6 
students who have IDA are heavy smoker and 4 out of 9 students that have ID are also 
heavy smoker. No statistically significant difference was observed among Hb tertile 
groups when compared with Age, students suffering from symptoms of anemia and 
students knowledge of anemia. As shown in Table 4.5 (b), No statistically significant 
difference was observed among Hb tertile groups when compared with SI, SF and 
TIBC. 
 
 
 
 
 
 
 
 
 
63.4%
8.1%8.3%
20.2%
54.8%
16.9%17.2%
11.1%
NoSeldomSome
Times
MuchNoSeldomSome
Times
Much
Smoke Cigarettes TobaccoSmoke water pipe
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Table 4.5 (a): Students characteristics by Hb tertile groups. Statistical analysis was 
performed by One way ANOVA. 
 
  
Hb Tertile groups 
P-
Values Total 
HbT1 
Hb < 11.00 
g/dl  
 
HbT2 
Hb 11.00 -
12.00 g/dl            
HbT3 
Hb >12.0 
g/dl  
Mean± SD  Mean± SD Mean± SD 
Mean± SD 
  
 
Age 
 
 
21±3 21 ± 3 21 ± 4 21± 3 >0.05 
 
MCV 
 
87.89 ± 6.22 76.93± 13.38 81.26 ± 7.63 88.29±5.62 <0.001 
 
Hct 
 
 
44.84 ± 5.51 27.33 ± 5.08 34.72 ± 1.52 45.48±4.61 <0.001 
Students habits 
(smoking , 
drinking coffee 
and tea 
 
3.75 ± 2.76 1.82 ± 1.66 2.82 ± 1.72 3.82 ± 2.78 0.031 
Students  
suffering from 
symptoms of 
anemia 
1.83 ±1.81 2.09 ± 1.58 1.00 ± 0.89 1.84 ±1.83 >0.05 
Students 
knowledge of 
anemia 
 
1.41± 1.58 1.00  ± 1.34 1.91 ± 1.30 1.41 ±1.59 >0.05 
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Table 4.5 (b): Students iron profile characteristics by Hb tertile groups. Statistical 
analysis was performed by One way ANOVA 
 
  
Hb Tertile groups 
P-Values 
Total 
HbT1 
Hb < 11.00 
g/dl  
 
HbT2 
Hb 11.00 -
12.00 g/dl            
HbT3 
Hb >12.0 g/dl  
Mean± SD  Mean± SD Mean± SD 
Mean± SD 
  
SI 
 
66.28±45.11 69.83 ± 92.50 45.50 ±30.73 68.15±34.43 >0.05 
SF 
 
55.00±65.80 88.20 ± 129.71 17.50 ±20.82 53.52±51.26 >0.05 
TIBC 
 
431.98±95.07 516.0± 124.65 434.75± 98.94 416.36± 83.31 >0.05 
 
 
Table 4.6 (a) shows the general characteristics of ID students (N=9).  The mean age and 
BMI of ID students were 21 Years old and 23.6 kg/m2 respectively.  Out of 9 ID 
students, 7 students (78%) were female. This table shows that 3 of ID students were 
from Ramallah Refugee camp and 3 of them were from Hebron city. The Distribution of 
university of ID students showed that 3 out of 9 students were from AAUJ and one of 
the students was from AQU. 
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 Table 4.6: General characteristics of ID students (N= 9). 
 
Abbreviations: AAUJ (Arab American University of Jenin, PPU (Palestine Polytechnic 
University – Hebron), AQU (Al-Quds University – Abu Dees). 
 
 
 
The general characteristics of IDA students (N=6) are described in table 4.7. All IDA 
students were female. The mean age and BMI of IDA students were 20 years old and 
21.1 kg/m2 respectively. 2 out of 6 IDA students were from Jenin city and 1 out of 6 
students were from refugee camp.  83% of IDA students were from medium family 
income.  
 
 
 
 
 
 
 
 
 
 
 
 
Age Sex 
BMI 
kg/m2 City Residence Smoking University 
Family 
Income 
23 Female 23 Ramallah 
Refugee 
Camp No 
Al- Quds 
Open 
University Low 
20 Female 23.8 Ramallah 
Refugee 
Camp No 
Al- Quds 
Open 
University Low 
19 Female 22 Ramallah Village No 
Al- Quds 
Open 
University Medium 
21 Female 24 Jenin 
Refugee 
Camp No AAUJ Medium 
20 Female 27.4 Jenin Village No AAUJ Medium 
21 Male 22.2 Hebron Village No PPU Low 
21 Male 25.1 Hebron City No PPU Medium 
21 Female 22.2 Hebron City Yes PPU Low 
21 Female 22 Abu Dees City No AQU High 
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Table 4.7: General characteristics of IDA students (N= 6). 
 
 
Age Sex 
BMI 
kg/m2 City Residence Smoking University 
Family 
Income 
19 Female 18.8 Jenin City No AAUJ Medium 
19 Female 21 Jenin City No AAUJ Medium 
19 Female 21.3 Hebron City No PPU Medium 
23 Female 21 Hebron Village No AQU Low 
21 Female 22 Bethlehem 
Refugee 
Camp No AQU Medium 
19 Female 22.4 Bethlehem Village No AQU Medium 
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Chapter Five 
Discussion 
 
IDA is the most common nutritional deficiency worldwide, affecting approximately a 
quarter of the global population, mostly in developing countries (Benoist et al., 2008; 
Luo et al., 2011b). The prevalence of ID varies greatly according to the host factors like 
age, gender, physiological causes, pathological causes, nutritional factors, 
environmental factors and socioeconomic conditions. (WHO and CDC, 2007).  
 
Adolescents are vulnerable to ID because of increased iron requirements related to rapid 
growth. Iron needs are highest in males during peak pubertal development because of a 
greater increase in blood volume, muscle mass and myoglobin. However, women in 
general and during their reproductive years are at risk of ID due to blood loss from 
menstruation, in particular that 10 % who suffer heavy loss. There are certain 
contraceptive practices also play a part, the intrauterine devices increase menstrual 
blood loss by 30 %- 50 % while oral contraceptives have the opposite effect. 
Furthermore, women in their reproductive years often have a dietary iron intake that is 
too low to offset losses from menstruation and the increased iron requirement for 
reproduction (Scholl, 2005). 
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A worldwide survey conducted by WHO and CDC and covering the years 1992-2005 
found that the prevalence of anemia among non pregnant women aged between 15–50 
years is 30.2% where the prevalence of anemia among men (15-50 years) is 12.7% 
worldwide. The prevalence of anemia ranges widely among developing and developed 
countries, where the prevalence of anemia among non pregnant women was 21.5% in 
the Western pacific, 19.0% in Europe, 32.4% in Eastern Mediterranean region which 
includes most Arabic countries and 17.8% in South East Asia (WHO and CDC,2008). 
Almost the entire population was covered by survey data or regression-based estimates, 
since all countries except for one had an estimate. The proportion of the population 
covered by survey data was high in non-pregnant women (73.5%), but lower for men 
(40.2%), and the elderly (39.1%) (WHO and CDC, 2008). 
 
This study aimed to assess the prevalence of ID and IDA among university students in 
Palestine and to assess the association between student Hb and SF level. The study 
subjects were 500 university students. The prevalence of anemia among the study 
subjects was 4.7% (23 out of 500) judged by Hb level (Hb < 12 g/dl). Based on the 
analysis of serum ferritin for students who have MCV < 80 fl, 20.9% (9 out of 43 
subjects) of the study subjects have depleted iron stores ( ID) and 14.0 % ( 6 out of 43 ) 
of the study have IDA. In general, the prevalence of IDA and ID varies according to 
different conditions.  
 
In Kavar Urban Area in Southern Iran, Haghpanah et al. (2011) found that 5.8% of 
adolescent  girls had anemia (Hb<12), 8.5% of them had ID (serum ferritin< 12) and 
1.7% of adolescent girls had IDA  (Hb<12 and serum ferritin< 12). Most of the anemic 
girls (85.7%) were in the mild range of anemia, only three of them had moderate anemia 
and severe anemia was not seen. There was not significant correlation between Hb 
concentration and SF, but a significant negative correlation between Hb concentration 
and TIBC (Haghpanah et.al, 2001). 
 
According to Palestinian Ministry of health, the percentage of women aged 15-49 years 
taking iron was only 7.1 % (PNA, 2005). When compared prevalence of IDA with 
neighboring countries, Prevalence of IDA among women (non pregnant) in Palestine is 
34.8% is higher than Lebanon (20%) and is better than reported ib Egypt (26.3%) and 
Jordan (28.2%) (PNA,2005).  
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In conclusion, our data revealed that the prevalence of ID is 1.8% (9 out of 500) and 
IDA 1.2% (6 out of 500) among university students in Palestine. A statistically 
significant difference was observed among the Hb tertile groups when compared with 
students habits include  smoking water pipe, smoking cigarettes tobacco, drinking 
coffee and tea (P= 0.031). No statistically significant difference was observed among 
Hb tertile groups when compared with Age, SI, SF, TIBC, students suffering from 
symptoms of anemia and students knowledge of anemia. Our study revealed that the 
level of university student’s general knowledge and background about anemia is very 
good, because 84.4% of students have enough knowledge about anemia as disease. On 
other hand 83.9% and 86.6% of students realize that poor nutrition and ID respectively, 
were the main cause of anemia. The result of their knowledge regarding poor nutrition 
and ID as main cause of anemia helps them protect themselves from the distribution of 
ID and IDA. 
Our data revealed that 92.4% of the students were medium and high family income, 
that’s mean that the medium and high social-economic level of individuals play a role in 
reduced figures of ID and IDA. 
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Recommendations 
Based on the interesting data revealed from the study and discussed, many 
recommendations could be assumed for the Palestinian Ministry of health, other health 
providers, community leaders, and students themselves. 
 The study highlights the high level of ID and IDA awareness among university 
students reflected in their knowledge about the disease and the medium 
economic and social levels through the low incidence of ID and IDA. 
 Prophylactic supplementation with iron could prevent the development of ID 
and IDA in target group and people with high risk. 
 Building up a national data base about ID and IDA among different groups in 
Palestine society such as pregnant women, school girls etc. 
 Similar study in Palestinian universities of Gaza in the future could have a 
comprehensive value and give clear comparative results that contribute to our 
results. 
 To keep the standard level of awareness in the next generation by demonstration 
of different activities warning from ID and IDA complication by students 
organizations. 
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 Enhancement of such research activities in Palestine by Palestinian Ministry of 
Health and other Health service providers in Palestine to prevent serious 
diseases by prevention of pathogenesis. 
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 جامعة القدس / كلية الدراسات العليا / أبو ديس
 نموذج استبيان للمشاركين في بحث حول مرض نقص الحديد و فقر الدم الناتج عنه
 
 ------------------------------رقم العينة: 
 ----------------------------------العمر:
 أنثى □ ذكر            □  جنس الطالب/ة :      
 رابعة □ ثالثة         □ ثانية         □ أولى             □السنة الدراسية:        
 ------------------------الكلية:  \الجامعة 
 ---------------------------------الطول:
 ---------------------------------الوزن:
 مخيم□ قرية        □نة            مدي □   مكان الإقامة:       
 ----------------------اسم المدينة/القرية: 
 لا يعمل □ يعمل            □ الأب:                  
 لا تعمل□ تعمل            □ الأم:                   
 عالي  □  متوسط         □           متدني :    □ مستوى الدخل في الأسرة
 شيقل ( 1113<)    (1192-1112(       )1191-1111(                             
   
     6أكثر من □       5-6 □            3-4  □              0-2□  عدد أفراد الأسرة:             
 
 لا□ نعم            □  ھل تعرف/ين ما ھو فقر الدم؟                      
  
 24
 
 
 ماذا يعني لك  فقر الدم ؟   -
 لا أعرف لا نعم 
    سوء تغذية        
    نقص الحديد         
    انخفاض في نسبة الدم        
   
 ھل يوجد لديك أي من السلوكيات التالية: -
 بكثرة  أحيانا            نادرا        لا               
     التدخين             
     الأرجيلة
شرب المنبهات ( القهوة و 
 الشاي) بعد الأكل مباشرة
    
     الإمساك المزمن أو الإسهال.
 
 ھل تعاني من أي من الاعراض التالية؟   
 لا أعرف لا نعم 
    صعوبة في التنفس        
    ضعف عام        
    فقدان للشهية        
    دوار        
    خمول و ارھاق        
    شحوب الوجه والشفاه
تراجع في الذاكرة و 
 الحفظ
   
   
 
 
 34
 
   .ھل تعتقد أن أي من الامراض التالية له علاقة بفقر الدم؟    3
 لا أعرف لا نعم 
قرحةة المعةدة والاثنةى 
 عشر
   
المعالجةةةةةة الطويلةةةةةة 
بالأسةةةةةةةةةةةةةةةبرين  و 
 المسكنات       
   
سةةةةةرقان القولةةةةةون 
  والمعدة.
   
اضةطرابات فةي القنةاة 
الهضةةةمية كالإسةةةهال 
 والتهاب المعدة
   
 
 
 شكرا لمشاركتكم في ھذا الاستبيان
 الطالبة:  تغريد السعدي
 / علم الدمالماجستير في العلوم الطبية المخبرية  
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   mrof tnesnoC -II
 
                             
 gnoma aimena ycneicifed nori dna ycneicifed nori fo ecnelaverP
 enitselaP ni stneduts ytisrevinu
 
 
 الموافقة المسبقة للطلبة
 
 الميلاد)________________ )______________________________________( تاريخ(الاسم
 
 قر الدم الناتج عنه.لقد تلقيت فكرة واضحة عن المشروع البحثي ، والمتعلق بمرض نقص الحديد و ف  -
  
لقد تلقيت معلومات كاملة من الباحث بشأن التفسيرات الممكنة والقيود المفروضة على الاختبارات موضوع  -
 البحث.
 
 ليس لدي المزيد من الأسئلة. -
 
أقر بأن مشاركتي قوعية تماما. وأنا حر لسحب مشاركتي دون إبداء أي سبب. وفي ھذه الحالة ، سيتم تجاھل  -
 البيانات الخاصة بي وعيناتي . ولا يشكل ھذا الانسحاب أي خسارة في الاستحقاقات بالنسبة لي.
 
أنا اوكد الموافقة على سحب عينة الدم الوريدي ، و بالتالي عمل فحوصات نسبة الحديد و متعلقاته في الدم  -
 والاختبارات ذات العلاقة
 
فى كاريتاس و مختبرات جامعة القدس لاتمام الفحوصات ضمن أوافق على إرسال عينة الدم خاصتي  الى مستش -
 مشروع البحث و لتخزينها لاستخدامات بحثية فقط.
 
 وبالإضافة إلى ذلك ، لقد قررت أنه بالإمكان استخدام عينتي كالتالي:
 
 يرجى الإجابة: نعم أو لا
 
 لا    نعم     
شاريع القدس لاستخدامها في م أن يتم تخزين عينات الدم الخاصة بي في مختبرات جامعة
 أخرى حول نفس الموضوع حتى أعلن انسحابي
  
شروع بحثي أتمنى أن أكون على إقلاع حول النتائج. لقد تم إبلاغي بأن النتائج تستند على م
 ولا تلبي معايير التشخيص الروتينية.
  
   سنوات في جامعة القدس. 11أوافق على أن نتائجي سيتم تخزينها مع البيانات لأكثر من 
 
 
 البريد الألكتروني  \التلفون 
 
 
 
 
 توقيع المشارك تاريخ التوقيع اسم الجامعة
 54
 
 
 
 انتشار نقص الحديد وفقر الدم الناتج عن نقص الحديد بين طلبة الجامعات في فلسطين.
  .تغريد يوسف السعدي : اعداد
  :  د. غسان بعلوشة اشراف 
 
 ملخص
في جميع أنحاء العالم التي تعتبر  ائية  الأكثر شيوعا̋ذواحدة من أھم المشاكل الغنقص الحديد ھي 
لنقص الحديد بسبب زيادة احتياجاتهم  ةعرض أكثر المراھقين  ،بمثابة السبب الرئيسي لفقر الدم
للحديد ھي أعلى بسبب زيادة حجم  الذكور حتياجاتا ،المرحلة ذهللحديد بسبب النمو السريع في ھ
عرضة لنقص  نجابالإن النساء خلال سنوات ابشكل عام فو ،لعضلات والميوجلوبين، كتلة ا الدم
 الحديد بسبب فقدان الدم من الدورة الشهرية.
  
نقص الحديد وفقر الدم الناتج عنه بين شريحة مهمة  نتشارالى تحديد مدى إلهذا ھدفت  ھذه الدراسة 
حيث  ، قولية ةتعتبر دراسھذه الدراسة  ، في المجتمع الفلسطيني وھم قلبة الجامعات في فلسطين
سنة   62-81عمارھم بين أم وريدي من قلاب جامعيين تراوحت عينة د 115شملت ھذه الدراسة 
بمساعدة ھؤلاء  ومن ثم قامت الباحثة ،الطوعي للمشاركة في ھذه الدراسة بدائهم القبولإوذلك بعد 
رض تسليط الضوء على الجوانب الاجتماعية بغ قامت بتصميمه مسبقا̋ ستبياناالطلبة في تعبئة 
التوزيع  ،لجوانب الأخرى مثل التاريخ الطبيھمال اإدية والصحية للطالب المشارك دون والاقتصا
 -ihCعن قريق (  حصائيا̋إحللت النتائج  ،ن وجدتإت الغذائية المختلفة افي والعاداالديمغر
 s’nosraePتواصلة و (م) للمتغيرات  ال tset -t( ،) AVONA) للمتغيرات الفئوية و (erauqs
 .الإحصائيةلاقات ع) لفحص الnoitalerroc
 
) وذلك 115من  32( %7.4ذه الدراسة عن نقص الحديد في ھالناتج فقر الدم  نتشارابلغت نسبة 
عتماد على تحليل بالاو ، (كورذلل  ld/g 5.31 <bHللإناث و  ld/g 21< bHعتماد على أن يكون (بالا
في  نقص)  من عينة الدراسة  كانوا يعانون من 34من  9( %9.12نسبة مخزون الحديد وجد أن 
) من عينة 34من  6( %1.41 أنوحيث وجد  lf 08 <VCM للطلاب  الذي  ) DIمخزون الحديد( 
 .ADI الدراسة يعانون من 
 64
 
 
كان ھناك اختلافات  bHعندما قمنا بتوزيع قلبة الجامعات في مجموعات ثلاثية بالاعتماد عل نسبة 
 في نتائج الطلبة بين ھذه المجموعات لدى مقارنتها بعادات الطلبة  المختلفة إحصائيةذات دلالة 
  إحصائيةذات دلالة لم تكن ھناك اختلافات   ، )130.0=P، الأرجيلة وشرب المنبهات) ( ( التدخين 
والطلاب  ، CBIT،  FS،  IS، في  نتائج الطلبة بين ھذه المجموعات لدى  مقارنتها مع العمر
من  ٪2.58وجدنا أن  ، فة ما ھو فقر الدمرمع ونون من أعراض فقر الدم والطلاب ذالذين يعا
وي ذمنهم كانوا من  ٪2.7و  ٪6.7الجامعات ينحدرون من أسر ذات دخل متوسط في  قلاب 
 الدخل المنخفض والعالي على التوالي.
 
كذلك مقدمي  ، وزارة الصحة الفلسطينية إلىة نتقدم بتوصيات واضحة وملح   فإنناوبناء على ما تقدم 
الخدمات الصحية في فلسطين أن يقدموا جانب من الاھتمام  بتلك التوصيات لتفادي ھذا المرض 
الشباب عبر تسليط الضوء عليه من خلال  لجياأ لدى  هوالحفاظ على معايير الوعي  بمخاقر
 لمحلي.كذلك قادة المجتمع اوالمنظمات والنوادي الطلابية المختلفة في الجامعات الفلسطينية 
 
 
 
 
